Title
COVID-19 Guideline Part 3: Molecular Testing
Authoring Organization
Publication Month/Year
September 5, 2023
Last Updated Month/Year
February 7, 2024
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
US
Document Objectives
The IDSA’s goal was to develop an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings and highlight important unmet research needs in the COVID-19 diagnostic testing space.
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital, Laboratory services
Intended Users
Epidemiology infection prevention, healthcare business administration, laboratory technician, nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Assessment and screening
Diseases/Conditions (MeSH)
D000086382 - COVID-19, D000087123 - COVID-19 Nucleic Acid Testing, D000086742 - COVID-19 Testing
Keywords
molecular testing, Coronavirus, covid-19, COVID